5 Ways Providers Can Start Reaching Healthcare’s Invisible Middle

By Sean Cassidy, CEO and co-founder, Lucem Health
LinkedIn: Sean Cassidy
LinkedIn: Lucem Health

Healthcare has become increasingly sophisticated at both ends of the care continuum. Prevention programs, wearables and wellness initiatives help healthy people stay healthy. Once disease is diagnosed, precision medicine uses biomarkers, genomics, advanced diagnostics and other patient-specific information to guide increasingly targeted treatment.

Between those two groups sits a large population that receives far less attention: people living with undiagnosed, misdiagnosed or undertreated disease.

Their conditions may be progressing for months or years while relevant signals accumulate across laboratory results, diagnoses, medications, imaging and routine encounters. They include people with early cardiovascular disease, cancer, metabolic disorders, autoimmune conditions and other illnesses that may generate actionable information before symptoms compel action.

This is healthcare’s “Invisible Middle.” For healthcare provider organization leaders looking for the next meaningful opportunity to improve outcomes while managing cost, it deserves greater attention.

Here are five places to start.

1. Look harder at the data you already have

Provider organizations have spent years accumulating clinical information. The immediate opportunity isn’t in collecting more of it. It is in making better use of the data that’s already available.

The signals associated with an emerging disease may not be obvious during any single encounter. However, as lab results, orders and observations accumulate over time, patterns emerge that can be used to focus on patients who warrant further evaluation.

For leaders who want more value from their data assets, there is a significant clinical and financial opportunity in finding such patterns. The key is being able to do it efficiently and early enough to influence care and, ultimately, patient outcomes.

2. Focus on diseases where earlier action changes the trajectory

Finding more risk isn’t inherently better. Providers already contend with alerts, care gaps and patient lists competing for clinicians’ attention. A useful early-detection program starts with a precisely targeted disease, population and care pathway. Is there a meaningful intervention available? Can earlier diagnosis change patients’ clinical trajectory? Is there an appropriate confirmatory test? Can we reach the patients we identify, and do we have the capacity to serve them once we do?

Those questions help distinguish a merely interesting analytical capability from a scalable process capable of improving care.

3. Treat prediction as the beginning of the workflow

Healthcare’s analytical capabilities have advanced considerably. But algorithms that identify elevated cancer or cardiovascular disease risk accomplish very little if identified patients never receive follow-up testing or treatment.

That handoff is where many promising programs fail. Someone must receive the finding, determine the appropriate next step, engage the patient, arrange testing, manage results and ensure follow-up. And all that needs to happen without simply adding another alert or action item to a work queue.

For any predictive program to succeed, healthcare providers should examine the pathway surrounding the prediction as closely as they evaluate the accuracy of the prediction itself.

4. Build for the patients who don’t arrive on their own

Much of healthcare delivery is designed around patients presenting with problems. Symptoms prompt appointments. Abnormal findings lead to referrals. Diagnoses activate treatment pathways.

The Invisible Middle doesn’t work that way.

These patients may feel healthy. They may not know they are at-risk and they certainly aren’t asking for help. Reaching them requires a proactive approach that identifies, engages and guides them toward appropriate evaluation before disease progression forces the encounter.

This has implications that go well beyond technology. Patient engagement, clinical capacity management, cost and payment considerations, and follow-up ownership all must become part of the solution design.

5. Measure what happens after the patient is identified

The most revealing metric for any early-detection program is not how many patients are flagged, it’s about what happens after patients are identified. How many were successfully contacted? How many completed recommended diagnostic testing? How many receive a positive (or negative) diagnosis? How quickly do patients reach appropriate care? Where do they drop out of the clinical pathway?

Those measures expose the operational barriers that model-performance statistics alone cannot. They also shift the focus toward the outcome that really matters: whether finding patients earlier actually improves their outcomes.

The undiagnosed diseases of the invisible middle are hidden in the mountains of data we already have, quietly progressing while we wait for patients to get uncomfortable enough to seek help. Providers that programmatically target this population will be competitive in a crowded market but most importantly, they’ll change, and even save, lives within the communities they have a duty to serve.